These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 27692696)

  • 1. De Ritis Ratio (AST/ALT) as a Significant Prognostic Factor in Patients With Upper Tract Urothelial Cancer Treated With Surgery.
    Lee H; Choi YH; Sung HH; Han DH; Jeon HG; Chang Jeong B; Seo SI; Jeon SS; Lee HM; Choi HY
    Clin Genitourin Cancer; 2017 Jun; 15(3):e379-e385. PubMed ID: 27692696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De Ritis ratio (aspartate transaminase/alanine transaminase ratio) as a significant prognostic factor after surgical treatment in patients with clear-cell localized renal cell carcinoma: a propensity score-matched study.
    Lee H; Lee SE; Byun SS; Kim HH; Kwak C; Hong SK
    BJU Int; 2017 Feb; 119(2):261-267. PubMed ID: 27226065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The De Ritis (aspartate transaminase/alanine transaminase) ratio as a predictor of oncological outcomes in patients after surgery for upper urinary tract urothelial carcinoma.
    Cho YH; Hwang JE; Chung HS; Kim MS; Hwang EC; Jung SI; Kang TW; Kwon DD; Choi SH; Kim HT; Kim TH; Kwon TG; Noh JH; Kim MK; Kim CS; Kang SG; Kang SH; Cheon J; Lee CH; Ku JY; Ha HK; Tae BS; Jeong CW; Ku JH; Kwak C; Kim HH
    Int Urol Nephrol; 2017 Aug; 49(8):1383-1390. PubMed ID: 28484945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic significance of preoperatively assessed AST/ALT (De Ritis) ratio on survival in patients underwent radical cystectomy.
    Gorgel SN; Kose O; Koc EM; Ates E; Akin Y; Yilmaz Y
    Int Urol Nephrol; 2017 Sep; 49(9):1577-1583. PubMed ID: 28669104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Preoperative Aspartate Transaminase/Alanine Transaminase Ratio as an Independent Predictive Biomarker in Patients With Metastatic Renal Cell Carcinoma Undergoing Cytoreductive Nephrectomy: A Propensity Score Matching Study.
    Ishihara H; Kondo T; Yoshida K; Omae K; Takagi T; Iizuka J; Tanabe K
    Clin Genitourin Cancer; 2017 Oct; 15(5):598-604. PubMed ID: 28495053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De Ritis (aspartate transaminase/alanine transaminase) ratio as a significant predictor of recurrence-free survival in patients with upper urinary tract urothelial carcinoma following nephroureterectomy.
    Nishikawa M; Miyake H; Fujisawa M
    Urol Oncol; 2016 Sep; 34(9):417.e9-417.e15. PubMed ID: 27180325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De Ritis Ratio (Aspartate Transaminase/Alanine Transaminase) as a Significant Prognostic Factor in Patients Undergoing Radical Cystectomy with Bladder Urothelial Carcinoma: A Propensity Score-Matched Study.
    Yuk HD; Jeong CW; Kwak C; Kim HH; Ku JH
    Dis Markers; 2019; 2019():6702964. PubMed ID: 31534562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Significance of Pre-to-Postoperative Dynamics of Aspartate Transaminase/Alanine Transaminase Ratio in Predicting the Prognosis of Renal Cell Carcinoma after Surgical Treatment.
    Kang M; Shin SJ; Sung HH; Jeon HG; Jeong BC; Jeon SS; Lee HM; Seo SI
    Dis Markers; 2020; 2020():8887605. PubMed ID: 32724485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High aspartate transaminase/alanine transaminase ratio predicts poor prognosis in patients with localized upper tract urothelial cancer: a propensity score-matched study in a large Chinese center.
    Li Y; Fang D; Bao Z; He A; Guan B; He S; Zhan Y; Gong Y; Li X; Zhou L
    Onco Targets Ther; 2019; 12():2635-2648. PubMed ID: 31114222
    [No Abstract]   [Full Text] [Related]  

  • 10. Association between De Ritis ratio (aspartate aminotransferase/alanine aminotransferase) and oncological outcomes in bladder cancer patients after radical cystectomy.
    Ha YS; Kim SW; Chun SY; Chung JW; Choi SH; Lee JN; Kim BS; Kim HT; Yoo ES; Kwon TG; Kim WT; Kim WJ; Kim TH
    BMC Urol; 2019 Jan; 19(1):10. PubMed ID: 30678673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The significance of De Ritis (aspartate transaminase/alanine transaminase) ratio in predicting pathological outcomes and prognosis in localized prostate cancer patients.
    Wang H; Fang K; Zhang J; Jiang Y; Wang G; Zhang H; Chen T; Shi X; Li Y; Duan F; Liu J
    Int Urol Nephrol; 2017 Aug; 49(8):1391-1398. PubMed ID: 28550473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative prognostic nutritional index is a significant predictor of survival in patients with localized upper tract urothelial carcinoma after radical nephroureterectomy.
    Huang J; Yuan Y; Wang Y; Chen Y; Kong W; Xue W; Chen H; Zhang J; Huang Y
    Urol Oncol; 2017 Dec; 35(12):671.e1-671.e9. PubMed ID: 28826702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Preoperative AST/ALT (De Ritis) Ratio Represents a Poor Prognostic Factor in a Cohort of Patients with Nonmetastatic Renal Cell Carcinoma.
    Bezan A; Mrsic E; Krieger D; Stojakovic T; Pummer K; Zigeuner R; Hutterer GC; Pichler M
    J Urol; 2015 Jul; 194(1):30-5. PubMed ID: 25623738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative aspartate transaminase/alanine transaminase ratio as a prognostic biomarker in primary non-muscle-invasive bladder cancer: a propensity score-matched study.
    Cheng X; Zhou X; Yi M; Xu S; Zhang C; Wang G
    BMC Urol; 2021 Sep; 21(1):136. PubMed ID: 34579695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic role of preoperative De Ritis ratio in upper tract urothelial carcinoma treated with nephroureterectomy.
    Mori K; Janisch F; Mostafaei H; Kimura S; Lysenko I; Karakiewicz PI; Briganti A; Enikeev DV; Rouprêt M; Margulis V; Chlosta P; Nyirady P; Babjuk M; Egawa S; Shariat SF
    Urol Oncol; 2020 Jun; 38(6):601.e17-601.e24. PubMed ID: 32127252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Value of Lymphovascular Invasion in Node-Negative Upper Urinary Tract Urothelial Carcinoma Patients Undergoing Radical Nephroureterectomy.
    Liu W; Zhou Z; Dong D; Sun L; Zhang G
    Yonsei Med J; 2019 Feb; 60(2):174-181. PubMed ID: 30666839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The De Ritis (Aspartate Transaminase/Alanine Transaminase) Ratio as a Prognosticator in Patients With End-stage Renal Disease-associated Renal Cell Carcinoma.
    Ikeda T; Ishihara H; Takagi T; Fukuda H; Yoshida K; Iizuka J; Kobayashi H; Okumi M; Ishida H; Kondo T; Tanabe K
    Clin Genitourin Cancer; 2020 Jun; 18(3):236-240.e1. PubMed ID: 31917171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-reactive protein: a biomarker of survival in patients with localized upper tract urothelial carcinoma treated with radical nephroureterectomy.
    Obata J; Kikuchi E; Tanaka N; Matsumoto K; Hayakawa N; Ide H; Miyajima A; Nakagawa K; Oya M
    Urol Oncol; 2013 Nov; 31(8):1725-30. PubMed ID: 23141922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is preoperative anemia a risk factor for upper tract urothelial carcinoma following radical nephroureterectomy?
    Yeh HC; Chien TM; Wu WJ; Li CC; Li WM; Ke HL; Chou YH; Wang CJ; Huang SP; Li CF; Liang PI; Huang CN
    Urol Oncol; 2016 Aug; 34(8):337.e1-9. PubMed ID: 27133951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variant histology as a significant predictor of survival after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma.
    Kim JK; Moon KC; Jeong CW; Kwak C; Kim HH; Ku JH
    Urol Oncol; 2017 Jul; 35(7):458.e9-458.e15. PubMed ID: 28347659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.